---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-002688"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2023-04-18T23:59:59+00:00"
generated_at: "2026-06-17T00:40:11.405060+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health FY2022 revenue down 10.5% to $50.3M; positive adjusted EBITDA, debt reduced 76%

## Summary
- Revenue $50.3M vs $56.2M; constant-currency increase of $0.4M; net loss $13.8M vs $7.96M.
- Adjusted EBITDA positive $0.5M (down from $3.3M in FY2021); going-concern doubt resolved.
- Cash & securities $21M (vs $0.3M); long-term debt cut to $5.1M from $21.4M.
- Raised $56.5M via equity/warrants; acquiring Cana Laboratories and ZipDoctor.
- R&D partnership with Cloudpharm for obesity/diabetes; launched Mediterranation supplements.

## SEC filing metadata
- accession: 0001477932-23-002688
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2023-04-18T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793223002688/0001477932-23-002688-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793223002688/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-002688
- JSON: https://secwatch.observer/filing/0001477932-23-002688.json
- Plain text: https://secwatch.observer/filing/0001477932-23-002688.txt

## Key facts
- Earnings Releases
  Cosmos Health Inc. reported fiscal year ended December 31, 2022 results: revenue $50.3 million, net income $(13,830,371).
  - Period: fiscal year ended December 31, 2022
  - Revenue: $50.3 million
  - Net income: $(13,830,371)
  - Result: reported results
  source text: devices, today provided a business update and reported financial results for the fiscal year ended December 31, 2022. Fiscal Year 2022 Financial Highlights · Revenues were $50.3 million versus $56.2 million in FY2021 with the decline being largely due to the high variation in FX differences between EUR and GBP to USD. When considered on a constant currency
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793223002688/0001477932-23-002688-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.